In-Lab Upfront Use of Tirofiban May Reduce the Occurrence of No-Reflow During Primary Percutaneous Coronary Intervention. A Pilot Randomized Study

por Lago, Igor Matos, Novaes, Gustavo Caires, Badran, André Vannucchi, Pavão, Rafael Brolio, Barbosa, Ricardo, de Figueiredo, Geraldo Luiz, Lima, Moysés de Oliveira, Haddad, Jorge Luiz, Schmidt, André, Marin, José Antônio
Publicado 2016